Immunocytokine with target cell-restricted IL-15 activity for treatment of acute lymphoblastic leukemia (ALL)

被引：0
|
作者：
Hagelstein, I [1 ,2 ]
Zekri, L. [1 ,2 ]
Klimovich, B. [1 ,2 ]
Lutz, M. S. [1 ,2 ]
Greve, C. [3 ]
Maerklin, M. [1 ,2 ]
Mueller, S. [1 ,2 ]
Schmied, B. J. [1 ,2 ]
Jung, G. [3 ]
Salih, H. R. [1 ,2 ]
机构：
[1] Univ Hosp Tubingen, Dept Internal Med, German Canc Consortium DKTK, Clin Collaborat Unit Translat Immunol, Tubingen, Germany
[2] Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Dept Immunol, Tubingen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V281
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [21] Fatal T/NK cell leukemia in IL-15 transgenic mice
    Fehniger, TA
    Suzuki, K
    Ponnappan, A
    VanDeusen, J
    Cooper, MA
    Robinson, M
    Durbin, J
    Caligiuri, MA
    FASEB JOURNAL, 2000, 14 (06): : A1024 - A1024
  • [22] FOUR NOVEL NUDT15 HAPLOTYPES RELEVANT FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Turner, Amy
    Aggarwal, Praful
    Scharer, Gunter
    Broeckel, Ulrich
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [23] Role of IL-2, IL-7, and IL-15 in allogeneic graft-vs-leukemia against acute lymphoblastic leukemia in a NOD/scid chimeric murine model
    Cipkala, DA
    Hendey, L
    Boyer, MW
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 58 - 59
  • [24] The Evaluation of Salivary Thromboplastic Activity of An Acute Lymphoblastic Leukemia (ALL) Case During Treatment
    Celkan, Tiraje
    Yarat, Aysen
    Akbay, Tugba Tunali
    Akyuz, Serap
    Pisiriciler, Rabia
    Yildiz, Inci
    MARMARA PHARMACEUTICAL JOURNAL, 2014, 18 (02) : 62 - 65
  • [25] IL-7R is essential for leukemia -initiating cell activity of T-cell acute lymphoblastic leukemia
    Gonzalez-Garcia, Sara
    Mosquera, Marta
    Fuentes, Patricia
    Palumbo, Tiziana
    Escudero, Adela
    Perez-Martinez, Antonio
    Ramirez, Manuel
    Corcoran, Anne E.
    Toribio, Maria L.
    BLOOD, 2019, 134 (24) : 2171 - 2182
  • [26] ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND CANCER PROCOAGULANT ACTIVITY
    POGLIANI, EM
    LANZAFAME, C
    BUCCIARELLI, P
    CORNEO, G
    HAEMATOLOGICA, 1991, 76 (06) : 526 - 527
  • [27] MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL)
    de Oliveira, Jaqueline C.
    Brassesco, Maria Sol
    Scrideli, Carlos Alberto
    Tone, Luiz Gonzaga
    Narendran, Aru
    PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 599 - 604
  • [28] B7-H3 (CD276) immunocytokines with target-cell restricted IL-15 activity for induction of anti-tumor immunity against leukemia and gastrointestinal tumors
    Schmied, B. J.
    Zekri-Metref, L.
    Maerklin, M.
    Pfluegler, M.
    Buehring, H. -J.
    Handgretinger, R.
    Kanz, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 240 - +
  • [29] Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
    Cheng Zhang
    Jiang F. Zhong
    Andres Stucky
    Xue-Lian Chen
    Michael F. Press
    Xi Zhang
    Clinical Epigenetics, 2015, 7
  • [30] Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
    Berger, A.
    Colpitts, S.
    Seabrook, M.
    Furlonger, C.
    Bendix, M.
    Moreau, J.
    McKillop, W.
    Medin, J.
    Paige, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1674 - 1675
12345